Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

"We cannot train for unemployment"

2009-11-16

The prestige forum was attended by, from the left: Prof. Dirk van Damme, Head of the Centre for Education research and innovation at OECD in Paris, France; Dr Saretha Brüssow of the Planning Unit: Teaching and Learning; Mr Francois Marais, Director of CHESD; Prof. Jonathan Jansen, Rector and Vice-Chancellor; Prof. Driekie Hay, Vice-Rector Academic Planning and the guest speaker; and Prof. Magda Fourie of the University of Stellenbosch.
Photo: Gerhard Louw

“We cannot train for unemployment. We must continuously look at what employers and the world want, and update,” Prof. Magda Fourie, Vice-Rector: Teaching and Learning at the University of Stellenbosch, recently said at a prestige forum for teaching and learning at the University of the Free State (UFS).

Prof. Fourie, former Vice-Rector: Academic Planning at the UFS delivered the second Magda Fourie Prestige Lecture at the forum. The forum was presented by the Centre for Higher Education Studies and Learning (CHESD) and the Planning Unit: Teaching and Learning. Various presentations were made on innovations in teaching and learning at the UFS.

Prof. Fourie said research has shown that the knowledge, skills, competencies and values of students are out of sync with the needs of the world out there. Higher Education must look at the context in which it operates and the relevance of its teaching and learning. “We are busy with the cultivation of humanity,” she said.

The UFS is doing excellent work with its bridging programmes and other universities will have to give attention to it. The UFS is also excellent in its extended programmes and have more women and foreign students than the national average. The UFS, however, has a lower percentage of black students than the national average.

The UFS is also excellent in terms of postgraduate students. The national average is 36%, with the UFS boasting 47%. Prof. Fourie expressed her concern for the low throughput in Business and Economics at the UFS where only 13% of those who enter the system graduate. “These are the people we need for this country’s economy.”

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept